(Q35544884)

8 August 2017

title

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta (English)

1 reference

8 August 2017

main subject

osteogenesis imperfecta

0 references

author name string

Aström E

series ordinal

1

1 reference

8 August 2017

Söderhäll S

series ordinal

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Archives of Disease in Childhood

8 August 2017

published in

1 reference

8 August 2017

volume

86

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

356-364

1 reference

Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathic juvenile osteoporosis.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Bisphosphonates in osteogenesis imperfecta

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Hypercalcaemia in osteogenesis imperfecta treated with pamidronate

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Osteogenesis imperfecta: A clinical study of the first ten years of life

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Therapy of osteogenesis imperfecta with synthetic salmon calcitonin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Genetic heterogeneity in osteogenesis imperfecta

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Bisphosphonates: from grandparents to grandchildren

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Bone mineral content and density in healthy subjects and in osteogenesis imperfecta

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Fluoride therapy in metabolic bone disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1751119

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

26 September 2018

1 reference

12 December 2020

Vital biomechanics: proposed general concepts for skeletal adaptations to mechanical usage

1 reference

12 December 2020

Hypercalciuria in children severely affected with osteogenesis imperfecta

1 reference

12 December 2020

Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta

1 reference

12 December 2020

[Osteogenesis imperfecta in childhood and adolescence]

1 reference

12 December 2020

Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)

1 reference

12 December 2020

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

12 December 2020

Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta

1 reference

12 December 2020

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

12 December 2020

Osteogenesis imperfecta: mosaicism and refinement of the genotype-phenotype map in OI type III. Mutations in brief no. 242. Online

1 reference

12 December 2020

Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients

1 reference

12 December 2020

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

1 reference

12 December 2020

Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management

1 reference

12 December 2020

Total body bone mineral and lean body mass by dual-photon absorptiometry. I. Theory and measurement procedure

1 reference

12 December 2020

Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate

1 reference

12 December 2020

Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta

1 reference

12 December 2020

Is APD a promising drug in the treatment of severe osteogenesis imperfecta?

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.86.5.356

1 reference

8 August 2017

1 reference

8 August 2017

1 reference